The Global Ablation Devices Market was valued at US$ 3,330.0 million in 2016 and is projected to expand at a CAGR of 10.9% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing popularity of minimally invasive surgical procedures is expected to be the major factor driving growth of the global ablation devices market over the foreseeable future.
Arrhythmia is a common type of cardiovascular disorder that affects a large population worldwide. states that atrial fibrillation is a growing serious health disorder that had affected 33.5 million people worldwide, which accounts 0.5% of total population share, in 2013. With the help of ablation devices, a large number of people suffering from these alarming diseases are now able to receive proper treatments.

Ablation devices are also used for the treatment of tumorigenic diseases such as cancer and several other serious diseases including neurological and small brain tumors. These devices are experiencing significant demand in the current healthcare scenario due to their efficacy and ease of use. Ablation offers numerous advantages over conventional surgery, in terms of increased safety, decreased scarring, and faster recovery. According to American Society of Plastic Surgeons, 5.8 million reconstructive minimally invasive surgeries were performed in 2013.

According to a research article published in the Heart Rhythm Journal in 2014, catheter ablation is suggested to be a safe, beneficial, and effective technique in maintaining sinus rhythm. Also, the catheter ablation possess lower mortality and stroke risks in adult patients as compared to the regular surgical procedures. Catheter ablation devices play a major role not only serving the geriatric patients but also younger patients, who can resume their everyday chores within a very less span of time after the surgery, as ablation takes minimal recovery duration. Moreover, number of types and techniques through which ablation is performed, also provide a wide array of choices to the patients and healthcare practitioners to choose a suitable type. For instance, a study published in the Journal of Atrial Fibrillation in 2015, states that cryoablation technique is better suited to treat atrio-ventricular nodal re-entry tachycardia (AVNRT) than radiofrequency ablation, as chances of permanent AV block are very less in cryoablation than that in radiofrequency. Doctors from Seattle Children’s suggest laser ablation for the treatment of epilepsy and brain tumors even in young children, as old as 2 years, due to the safety and precision offered by it. Thus, the demand for ablation devices is expected to witness dramatic growth in the near future, creating lucrative opportunities for the market players to grab more sales with the introduction of cost-efficient and innovative devices.

Key Takeaways of the Ablation Devices Market:

The global ablation devices market is expected to expand at a CAGR of 10.9% during the forecast period (2016–2025), as there exists a huge potential market, especially in Asia Pacific, Latin America, Middle East, and Africa

Robust developments in surgical procedures and adoption of minimally invasive surgical procedures are expected to drive the global ablation devices market.

Atrial Fibrillation, Arrhythmia, Lung Cancer, Breast Cancer, AV node cancer as well as Brain Tumors, and Pancreatic & Kidney tumors are the major therapeutic applications, where various types of ablation can be performed and remain as potential application areas in the global ablation devices market.

Some of the major players involved in the global ablation devices market includes, Arthrex, Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Inc., Halyard Health, Abbott Laboratories, EDAP TMS S.A., AtriCure, Inc., and Smith & Nephew.